PASS Research Analyst Certification Exam

Imagine you are conducting due diligence on a mid-cap brokerage firm whose retail client base has grown exponentially over the last two quarters.

You have spent the last three weeks deep-diving into the quarterly earnings of a leading infrastructure firm. Your valuation model is nearly complete, and you are preparing to publish a 'Buy' recommendation that is...

Imagine you have just finalized a comprehensive research report on a prominent Indian IT services firm, projecting a significant upside based on upcoming quarterly results. As you prepare to publish, your firm’s...

You are reviewing the daily chart of a mid-cap IT stock listed on the NSE, which has been consolidating for weeks. Your fundamental model suggests the stock is undervalued, but you need a tactical entry point to maximize...

Imagine you are finalizing a research note on a mid-cap IT stock showing signs of a breakout after months of stagnation. The price has just crossed its 200-day moving average, and the bullish sentiment is palpable in the...

Imagine you are drafting an equity research note on an emerging mid-cap IT firm. You want to demonstrate that the stock is displaying superior momentum compared to the Nifty IT index, but the absolute price...

Imagine you are finalizing an investment thesis on a mid-cap brokerage firm listed on the NSE. Your valuation model looks robust, but during your due diligence, you discover that the person executing large proprietary...

You are deep into your research on a mid-cap manufacturing firm in the Nifty 500. The headline figures look spectacular: the Return on Equity (ROE) has climbed steadily to 25%, a level that usually signals a competitive...

Imagine you have just finalized a complex valuation model for a mid-cap infrastructure firm. After submitting the report to your compliance officer, you receive an automated alert requiring you to archive your...

Picture a high-stakes meeting at a Mumbai-based investment firm where you are tasked with presenting a deep-dive analysis on a pharmaceutical conglomerate. Your manager leans over and asks for your credentials, not...